Etanercept Reduces Neuroinflammation and Lethality in Mouse Model of Japanese Encephalitis
Open Access
- 20 March 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (6) , 875-889
Abstract
Background. Japanese encephalitis virus (JEV) is a neurotropic flavivirus that causes Japanese encephalitis (JE), which leads to high fatality rates in human. Tumor necrosis factor alpha (TNF-α) is a key factor that mediates immunopathology in the central nervous system (CNS) during JE. Etanercept is a safe anti-TNF-α drug that has been commonly used in the treatment of various human autoimmune diseases. Methods. The effect of etanercept on JE was investigated with a JEV-infected mouse model. Four groups of mice were assigned to receive injections of phosphate-buffered saline, etanercept, JEV, or JEV plus etanercept. Inflammatory responses in mouse brains and mortality of mice were evaluated within 23 days post infection. Results. The in vitro assay with mouse neuron/glia cultures showed that etanercept treatment reduced the inflammatory response induced by JEV infection. In vivo experiments further demonstrated that administration of etanercept protected mice from JEV-induced lethality. Neuronal damage, glial activation, and secretion of proinflammatory cytokines were found to be markedly decreased in JEV-infected mice that received etanercept treatment. Additionally, etanercept treatment restored the integrity of the blood–brain barrier and reduced viral load in mouse brains. Conclusions. Etanercept effectively reduces the inflammation and provides protection against acute encephalitis in a JEV-infected mouse model.Keywords
Funding Information
- National Natural Sciences Foundation of China (31172325)
- 973 Project of China (2010CB530100)
- Special Fund for Agro-scientific Research in the Public Interest (201203082)
- New Century Excellent Talents in University (NCETNCET-10-0422)
- Fundamental Research Funds for the Central University (2011PY002, 2013PY051)
This publication has 36 references indexed in Scilit:
- Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseasesBrain Research Bulletin, 2012
- Regulation of microglia effector functions by tumor necrosis factor signalingGlia, 2011
- Chemokine profiling of Japanese encephalitis virus-infected mouse neuroblastoma cells by microarray and real-time RT-PCR: Implication in neuropathogenesisVirus Research, 2010
- Japanese Encephalitis—A Pathological and Clinical PerspectivePLOS Neglected Tropical Diseases, 2009
- Viral encephalitis and epilepsyEpilepsia, 2008
- Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitisGlia, 2007
- Brain Inflammation in Epilepsy: Experimental and Clinical EvidenceEpilepsia, 2005
- Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitisNature Medicine, 2004
- Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patientsJournal of Medical Virology, 1997
- The influence of cytokines on the integrity of the blood-brain barrier in vitroJournal of Neuroimmunology, 1996